CN120752249A - 化合物及使用了该化合物的标记生物物质 - Google Patents

化合物及使用了该化合物的标记生物物质

Info

Publication number
CN120752249A
CN120752249A CN202480014018.9A CN202480014018A CN120752249A CN 120752249 A CN120752249 A CN 120752249A CN 202480014018 A CN202480014018 A CN 202480014018A CN 120752249 A CN120752249 A CN 120752249A
Authority
CN
China
Prior art keywords
group
residue
compound
substituent
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480014018.9A
Other languages
English (en)
Chinese (zh)
Inventor
白兼研史
吉光佑二
滨田直佳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fujifilm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm Corp filed Critical Fujifilm Corp
Publication of CN120752249A publication Critical patent/CN120752249A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
CN202480014018.9A 2023-02-27 2024-02-27 化合物及使用了该化合物的标记生物物质 Pending CN120752249A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023-028798 2023-02-27
JP2023028798 2023-02-27
PCT/JP2024/007132 WO2024181455A1 (ja) 2023-02-27 2024-02-27 化合物及びこれを用いた標識生体物質

Publications (1)

Publication Number Publication Date
CN120752249A true CN120752249A (zh) 2025-10-03

Family

ID=92589824

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480014018.9A Pending CN120752249A (zh) 2023-02-27 2024-02-27 化合物及使用了该化合物的标记生物物质

Country Status (5)

Country Link
US (1) US20250389724A1 (https=)
EP (1) EP4674861A1 (https=)
JP (1) JPWO2024181455A1 (https=)
CN (1) CN120752249A (https=)
WO (1) WO2024181455A1 (https=)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018238A1 (en) 1999-09-10 2001-03-15 Oncoimmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
EP0967219A4 (en) 1997-07-11 2002-09-11 Rikagaku Kenkyusho CONNECTIONS WITH ENERGY TRANSFER FUNCTION AND A METHOD FOR DNA BASE SEQUENCING USING THESE CONNECTIONS
CA2421582A1 (en) 2000-09-11 2002-03-21 The Trustees Of Columbia University In The City Of New York Combinatorial fluorescence energy transfer tags and uses thereof
CA2423806C (en) 2000-09-29 2009-12-22 Molecular Probes, Inc. Modified carbocyanine dyes and their conjugates
US20160095939A1 (en) 2014-10-07 2016-04-07 Immunomedics, Inc. Neoadjuvant use of antibody-drug conjugates
WO2010117420A2 (en) 2009-03-30 2010-10-14 Pacific Biosciences Of California, Inc. Fret-labeled compounds and uses therefor
CN104955484B (zh) * 2012-08-15 2019-01-15 文森医学公司 用于前列腺癌成像的前列腺特异性抗原药剂及其使用方法
GB201220010D0 (en) 2012-11-07 2012-12-19 Oxford Biotherapeutics Ltd Therapeutic amd diagnostic target
CN116059395A (zh) 2015-06-29 2023-05-05 第一三共株式会社 用于选择性制造抗体-药物缀合物的方法
JP7097885B2 (ja) * 2016-12-12 2022-07-08 ベクトン・ディキンソン・アンド・カンパニー 水溶性ポリマー色素
RU2731211C1 (ru) 2017-03-21 2020-08-31 Фуджифилм Корпорэйшн Пептидное соединение и способ его получения, композиция для скринингового использования и способ отбора пептидного соединения
WO2019013707A1 (en) * 2017-07-11 2019-01-17 Agency For Science, Technology And Research MIMETALS OF GLYCOSAMINOGLYCAN PENETRATING CELLS
JP2019172826A (ja) 2018-03-28 2019-10-10 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
JP7064583B2 (ja) 2018-06-01 2022-05-10 富士フイルム株式会社 蛍光性化合物及びこれを用いた蛍光標識生体物質
EP3916000B1 (en) 2019-02-28 2026-04-08 FUJIFILM Corporation Method for producing peptide compound, protecting group-forming reagent, and aromatic heterocyclic compound
JP7344982B2 (ja) 2019-11-21 2023-09-14 富士フイルム株式会社 化合物及びこれを用いた蛍光標識生体物質
WO2022025210A1 (ja) 2020-07-30 2022-02-03 富士フイルム株式会社 化合物及びこれを用いた標識生体物質
JP7550076B2 (ja) * 2021-02-26 2024-09-12 富士フイルム株式会社 蛍光色素及びこれを用いた標識生体物質
JP7748830B2 (ja) 2021-08-20 2025-10-03 伊藤ハム株式会社 フライ食品の製造方法

Also Published As

Publication number Publication date
US20250389724A1 (en) 2025-12-25
EP4674861A1 (en) 2026-01-07
WO2024181455A1 (ja) 2024-09-06
JPWO2024181455A1 (https=) 2024-09-06

Similar Documents

Publication Publication Date Title
JP7344982B2 (ja) 化合物及びこれを用いた蛍光標識生体物質
JP7550076B2 (ja) 蛍光色素及びこれを用いた標識生体物質
US12522609B2 (en) Compound and labeled biological substance using the same
US20240173437A1 (en) Compound and labeled biological substance using the same
WO2021125295A1 (ja) 化合物及びこれを用いた蛍光標識生体物質
US20250314658A1 (en) Fluorescence intensity enhancer, fluorescence intensity enhancing method of fluorescently labeled target biological substance, and kit for fluorescence detection
JP7787670B2 (ja) 化合物及びこれを用いた標識生体物質
US20240182383A1 (en) Compound and labeled biological substance using the same
CN117642413A (zh) 化合物及使用了该化合物的标记生物物质
JP7441306B2 (ja) 化合物及びこれを用いた標識生体物質
CN120752249A (zh) 化合物及使用了该化合物的标记生物物质
CN120752250A (zh) 化合物及使用了该化合物的标记生物物质
CN117642412A (zh) 化合物及使用了该化合物的标记生物物质
WO2024181456A1 (ja) 化合物及びこれを用いた標識生体物質
CN117642414A (zh) 化合物及使用了该化合物的标记生物物质
CN117460789B (zh) 化合物及使用了该化合物的标记生物物质
CN117460790B (zh) 荧光性化合物及使用了该荧光性化合物的荧光标记生物物质
WO2025197851A1 (ja) 蛍光性化合物
JP2023059377A (ja) 蛍光性化合物及びこれを用いた蛍光標識生体物質

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination